CancerLinQ LLC, a wholly owned nonprofit subsidiary of ASCO, has announced that the University of Virginia Cancer Center has signed an agreement to participate in the CancerLinQ ® platform.
“As CancerLinQ ® continues to rapidly grow, we are thrilled to have the University of Virginia Cancer Center join our network of oncology practices,” said CancerLinQ LLC Chief Executive Officer Kevin Fitzpatrick. “This large academic institution will be a great ally in our goal of improving cancer care through aggregating and analyzing patient records.”
CancerLinQ ® is a powerful platform containing growing amounts of real-world cancer information. This national initiative will allow cancer providers to improve the quality and value of care by analyzing millions of cancer patient medical records, uncovering patterns and trends, and measuring their care against that of their peers and recommended guidelines.
The University of Virginia Cancer Center, a National Cancer Institute–designated cancer center, is one of many academic medical centers to join the CancerLinQ ® initiative. To date, over 75 practices in 40 states, representing more than 1,500 oncologists, have signed agreements to participate in CancerLinQ ®. To see the full list of practices currently participating, visit http://cancerlinq.org/care-team.
CancerLinQ ® is a project of CancerLinQ LLC. For more information, please visit CancerLinQ.org. ■
© 2017. American Society of Clinical Oncology. All rights reserved.